Biden and Harris tout drug price cuts at joint rally
The Democrats announced a deal with pharmaceutical companies to cut Medicare prices for 10 top-selling drugs
What happened
President Joe Biden and Vice President Kamala Harris appeared together Thursday to celebrate Medicare's first successful price negotiation with drugmakers, as allowed under Biden's 2022 Inflation Reduction Act (IRA). Medicare will pay 38% to 79% below list price for 10 top-selling drugs when the newly negotiated prices take effect in 2026, saving taxpayers a projected $6 billion a year and Medicare beneficiaries $1.5 billion.
Who said what
The first joint appearance by Biden and Harris since the president dropped out of the race was "billed as an official White House policy event," but it "quickly took on the tone and feel of a campaign rally," The Washington Post said. "We finally beat Big Pharma," Biden told the crowd in Largo, Maryland, and "with not one Republican vote in the entire Congress." He called Harris, who provided the tie-breaking Senate vote for the IRA, an "incredible partner in the progress we've made," adding, "she's going to make one hell of a president."
Donald Trump, in a meandering press conference shortly afterward, called the IRA a "con job" and said he was "entitled to personal attacks" on Harris. "I don't have a lot of respect for her intelligence, and I think she'll be a terrible president," he said.
What next?
Medicare plans to negotiate lower prices on 15 more drugs in 2025 and 2026, and 20 drugs in the following years. It's not clear how much the price reductions will help individual beneficiaries, but the IRA's $2,000-a-year cap on personal drug spending and $35 monthly ceiling on insulin costs take effect for Medicare patients next year.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Quiz of The Week: 3 – 9 JanuaryQuiz Have you been paying attention to The Week’s news?
-
The Week Unwrapped: Is Elon Musk’s AI tool a platform for abuse?Podcast Plus can Mumsnet predict who will be the next PM? And who is still watching Avatar sequels?
-
The week’s best photosIn Pictures A fireman's ladder, a race through the desert, and more
-
Trump pulls US from key climate pact, other bodiesSpeed Read The White House removed dozens of organizations from US participation
-
Trump fears impeachment if GOP loses midtermsSpeed Read ‘You got to win the midterms,’ the president said
-
‘Let 2026 be a year of reckoning’Instant Opinion Opinion, comment and editorials of the day
-
‘This is a structural weakening of elder protections’Instant Opinion Opinion, comment and editorials of the day
-
House GOP revolt forces vote on ACA subsidiesSpeed Read The new health care bill would lower some costs but not extend expiring Affordable Care Act subsidies
-
Senate votes down ACA subsidies, GOP alternativeSpeed Read The Senate rejected the extension of Affordable Care Act tax credits, guaranteeing a steep rise in health care costs for millions of Americans
-
Are Republicans going to do a deal on health care?Today's Big Question Obamacare subsidies are expiring soon
-
Trump’s Ukraine peace talks advance amid leaked callSpeed Read Trump’s envoy Steve Witkoff is set to visit Russia next week
